Security key
88032L605
TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX)
CUSIP: 88032L605
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 2,006,422
- Total 13F value
- $13,111,231
- Share change
- +644,232
- SEC-reported price per share
- $6.55
- Number of holders
- 23
- Value change
- +$4,224,591
- Number of buys
- 9
- Number of sells
- 5
- Shares outstanding
- 37,442,071
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
23
Top holders
10
TENX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
TENAX THERAPEUTICS, INC. SEC filings
TENAX THERAPEUTICS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88032L605
Recent filing periods:
Ownership snapshot
Top reported holders of TENX - TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vestal Point Capital, LP
Disclosed value leader
Vestal Point Capital, LP
Comparable rows
15/15
Latest evidence
31 Dec 2024
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Vestal Point Capital, LP
Showing 1-6 of 15 holder rows.
Quick read
Vestal Point Capital, LP leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vestal Point Capital, LP's linked filing trail.
Comparable ownership
Top 5
Vestal Point Capital, LP
9.9%
S.H.N. Financial Investments Ltd.
5%
BVF INC/IL
0.91%
Venrock Adviser, LLC
0.56%
Vivo Capital, LLC
0.56%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vestal Point Capital, LP |
13D/G
13F
Company
|
9.9%
|
$18,525,720
2,470,096 shares
|
$0 | 30 Sep 2024 |
| S.H.N. Financial Investments Ltd. |
13D/G
|
5%
|
$1,052,814
179,050 shares
|
$0 | 31 Dec 2024 |
| BVF INC/IL |
13F
Company
|
0.91%
|
$2,101,808
339,549 shares
|
— | 31 Dec 2024 |
| Venrock Adviser, LLC |
13F
Company
|
0.56%
|
$1,289,581
208,333 shares
|
— | 31 Dec 2024 |
| Vivo Capital, LLC |
13F
Company
|
0.56%
|
$1,289,581
208,333 shares
|
— | 31 Dec 2024 |
| Janus Henderson Group Ltd. |
13F
Company
|
0.45%
|
$1,025,829
166,666 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
2,006,422
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q3 2025 Across Filers
Q3 2025 holders
34
Q1 2025 holders
23
Holder diff
-11
| Investor | Q3 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend